Registry for patients with severe asthma in the UK
Co-morbidity and Refractory Asthma - UK Severe Asthma Registry
This study collects information from patients with severe asthma in the UK to help improve understanding and treatment of their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4800 (estimated) |
| Ages | 16 Years and up |
| Sex | All |
| Sponsor | Queen's University, Belfast Academic / other |
| Locations | 1 site (Belfast) |
| Trial ID | NCT04553276 on ClinicalTrials.gov |
What this trial studies
The UK Severe Asthma Registry collects clinical data from patients attending specialized severe asthma clinics across the UK to enhance understanding and treatment of difficult asthma. Since its inception in 2007, the registry has been gathering anonymized information on patient demographics, disease characteristics, and treatment responses, ensuring strict confidentiality. Data is entered by clinical teams after obtaining informed consent from patients, and it is used to standardize clinical services and facilitate research into severe asthma management.
Who should consider this trial
Good fit: Ideal candidates for this registry are individuals referred to a specialist severe asthma clinic in the UK due to inadequate asthma control.
Not a fit: Patients who do not have severe asthma or are not referred to a specialist clinic may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could lead to improved treatment strategies and outcomes for patients with severe asthma.
How similar studies have performed: Other clinical registries have shown success in improving patient outcomes and standardizing care, indicating that this approach is promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Referral to a specialist severe asthma clinic in the UK due to inadequate asthma control Exclusion Criteria: None
Where this trial is running
Belfast
- Queen's University Belfast — Belfast, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Liam Heaney
- Email: l.heaney@qub.ac.uk
- Phone: +44 (0)28 9097 6376
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.